Shots:

• The agreement will focus on commercialization of kidney organoid technology- for generation of human pluripotent stem cell-derived kidney organoids
• This technology enables the growth of organoids/ mini-organs- having key features of renal development and physiology in vitro and is developed by one of the professor at Brigham and Women’s Hospital
• The kidney organoids provide reproductive and adaptable framework for forming renal physiology- injury and disease at developmental stages

Ref:  Stemcell Technologies | Image: Kevin Hardiman